When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 21 Apr 2025
Last updated: 10 Feb 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • fever
  • cough
  • myalgia
  • dyspnoea

Other diagnostic factors

  • chills or rigors
  • malaise
  • headache
  • watery diarrhoea
  • tachypnoea
  • tachycardia
  • cyanosis
  • nausea and vomiting
  • sore throat
  • sputum production
  • chest pain
  • pleurisy
  • rhinorrhoea
  • dizziness
  • arthralgia
  • abdominal pain
  • seizure
  • delirium
  • rales
  • inspiratory crackles
  • bronchial breathing

Risk factors

  • travel to affected area
  • close contact with infected individuals
  • laboratory work on SARS-CoV

Diagnostic investigations

1st investigations to order

  • FBC
  • aminotransferases
  • lactate dehydrogenase
  • creatine kinase
  • blood culture
  • sputum culture
  • nasopharyngeal virus culture
  • direct immunofluorescent antibody staining
  • chest x-ray
  • pulse oximetry
  • reverse-transcription polymerase chain reaction (RT-PCR)

Investigations to consider

  • ABG
  • coagulation screen
  • high-resolution CT (HRCT) of thorax
  • serological testing for SARS-CoV-specific antibodies
  • viral culture

Emerging tests

  • rapid immunoswab assay for SARS-CoV detection
  • monoclonal antibodies

Treatment algorithm

Contributors

Authors

Georgia G. Pitsiou, MD, PhD
Georgia G. Pitsiou

Associate Professor in Pulmonary Medicine

Aristotle University of Thessaloniki

Respiratory Failure Clinic

General Hospital G. Papanikolaou

Thessaloniki

Greece

Disclosures

GGP declares that she has no competing interests.

Ioannis P. Kioumis, MD, PhD
Ioannis P. Kioumis

Professor in Pulmonary Medicine

Infectious Diseases

Aristotle University of Thessaloniki

Respiratory Failure Clinic

General Hospital G. Papanikolaou

Thessaloniki

Greece

Disclosures

IPK declares that he has no competing interests.

Peer reviewers

Tommy R. Tong, MD

Attending Pathologist

Montefiore Medical Center

Bronx

NY

Disclosures

TRT declares that he has no competing interests.

Sian Griffiths, OBE, MA, MB BChir, FFPHM, FRCP (Lon), FRCP (Edin), FHKCCM

Director of the School of Public Health

Chinese University of Hong Kong

Prince of Wales Hospital

New Territories

Hong Kong

Disclosures

SG declares that she has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Christian MD, Poutanen SM, Loutfy MR, et al. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1420-1427.Full text  Abstract

Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772. Abstract

Mahony JB, Richardson S. Molecular diagnosis of severe acute respiratory syndrome: the state of the art. J Mol Diagn. 2005;7:551-559. Abstract

Peiris JS, Yuen KY, Osterhaus AD, et al. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431-2441. Abstract

Fowler RA, Lapinsky SE, Hallet D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:367-373.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer